| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,003 | 0,009 | 07:00 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | Wesana Health Holdings Inc: Wesana Health Holdings delisted from CSE | 1 | Stockwatch | ||
| WESANA HEALTH Aktie jetzt für 0€ handeln | |||||
| 30.10. | CSE Bulletin: Delist - Wesana Health Holdings Inc. (WESA.X) | 525 | Newsfile | Le 30 octobre/October 2026
The Subordinate Voting Shares of Wesana Health Holdings Inc. will be delisted from the CSE at market close today, October 30, 2026.
Wesana Health Holdings Inc. is currently... ► Artikel lesen | |
| 02.10. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | 3.636 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,760 | +2,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ESSILORLUXOTTICA | 174,95 | -0,09 % | 1,8 Milliarden Menschen mit Alterssichtigkeit: Warum Alcon und EssilorLuxottica neue Sehlösungen entwickeln | ||
| SERNOVA BIOTHERAPEUTICS | 0,059 | 0,00 % | Sernova Biotherapeutics: 11,2 Millionen Dollar für die Fusion - und doch rutscht die Aktie | ||
| ALIGN TECHNOLOGY | 145,00 | -0,41 % | Align Technology beruft zwei neue Mitglieder in den Verwaltungsrat | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Medical Devices Provides Update on Health Canada Licence Application | Toronto, Ontario--(Newsfile Corp. - November 13, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a developer of needle-free drug delivery technology, provides an update regarding... ► Artikel lesen | |
| HEALWELL AI | 0,306 | -3,77 % | HEALWELL AI: HEALWELL More than Doubles YoY Adjusted EBITDA in Q3-2026 and Improves YTD Operating Cashflow by $26 Million | HEALWELL achieved revenue from continuing operations of $32.6 million in Q3-2026, an increase of 7% compared to revenue of $30.4 million in Q3-2025.HEALWELL reported positive Adjusted EBITDA1 of $1.6... ► Artikel lesen | |
| INMODE | 11,420 | -1,34 % | InMode Ltd.: InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial Outlook | YOKNEAM, Israel, Nov. 11, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,570 | -2,48 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SPINEWAY | 0,093 | +8,63 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| ELEVANCE HEALTH | 352,80 | 0,00 % | What Argus Sees in Elevance Health (ELV) for 2027 | ||
| MORE LIFE COMPANY | 0,022 | -10,37 % | XFRA NEW INSTRUMENTS AVAILABLE ON 24.08.2026 | The following instruments on XETRA do have their first trading 24.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.08.2026
Aktien
1 CA0966311064 Boardwalk Real Estate... ► Artikel lesen | |
| VERU | 2,030 | -3,79 % | Veru presents data on enobosarm for obesity treatment | ||
| BONESUPPORT | 28,740 | +0,21 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q3 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2026.
"Strong growth and important progress... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,470 | +1,17 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| TEMPEST THERAPEUTICS | 0,295 | -3,73 % | Tempest Therapeutics GAAP EPS of -$0.21 beats by $0.11 |